Trump's 100% pharma tariff raises global concerns
pre-market1 source ↓written by the desknot a recommendation
- on select pharmaceutical
- 100% tariff
US President Donald Trump has announced a 100% tariff on select pharmaceutical imports, escalating trade tensions globally. Jefferies reports that while this move raises concerns, Indian generics are likely to remain exempt from these tariffs due to potential drug shortages in the US. This could provide a buffer for Indian drug exporters amidst rising global trade tensions.
Not investment advice. For informational purposes only.